EWS RNA binding protein 1 ; Homo sapiens






203 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
51 17149955 Comparative analysis of routine histology, immunohistochemistry, reverse transcriptase polymerase chain reaction, and fluorescence in situ hybridization in diagnosis of Ewing family of tumors. Arch Pathol Lab Med 2006 Dec 2
52 17202261 Multiple aromatic side chains within a disordered structure are critical for transcription and transforming activity of EWS family oncoproteins. Proc Natl Acad Sci U S A 2007 Jan 9 1
53 17425403 Signature-based small molecule screening identifies cytosine arabinoside as an EWS/FLI modulator in Ewing sarcoma. PLoS Med 2007 Apr 4
54 17438102 Cholecystokinin down-regulation by RNA interference impairs Ewing tumor growth. Clin Cancer Res 2007 Apr 15 4
55 17487851 Cytologic diagnosis of Ewing sarcoma/peripheral neuroectodermal tumor with paired prospective molecular genetic analysis. Cancer 2007 Jun 25 1
56 17700534 The sensitivity of the Ewing's sarcoma family of tumours to fenretinide-induced cell death is increased by EWS-Fli1-dependent modulation of p38(MAPK) activity. Oncogene 2008 Feb 7 13
57 18212050 Inducible expression of chimeric EWS/ETS proteins confers Ewing's family tumor-like phenotypes to human mesenchymal progenitor cells. Mol Cell Biol 2008 Apr 1
58 18300804 Clear cell sarcoma of soft tissue: a clinicopathologic, immunohistochemical, and molecular analysis of 33 cases. Am J Surg Pathol 2008 Mar 4
59 18310898 Treatment of Ewing's sarcoma using an antisense oligodeoxynucleotide to regulate the cell cycle. Biol Pharm Bull 2008 Mar 3
60 18622580 Neural differentiation arrest in embryonal carcinoma cells with forced expression of EWS-FLI1. J Neurooncol 2008 Nov 1
61 18698489 EWS is a substrate of type I protein arginine methyltransferase, PRMT8. Int J Mol Med 2008 Sep 14
62 18989890 Phase II study of intermediate-dose cytarabine in patients with relapsed or refractory Ewing sarcoma: a report from the Children's Oncology Group. Pediatr Blood Cancer 2009 Mar 1
63 19076070 Phosphorylation of Ewing's sarcoma protein (EWS) and EWS-Fli1 in response to DNA damage. Biochem J 2009 Mar 15 6
64 19151750 O-GlcNAcylation is involved in the transcriptional activity of EWS-FLI1 in Ewing's sarcoma. Oncogene 2009 Mar 5 8
65 19205734 Simultaneous inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways augment the sensitivity to actinomycin D in Ewing sarcoma. J Cancer Res Clin Oncol 2009 Aug 1
66 19247449 EWS/ETS regulates the expression of the Dickkopf family in Ewing family tumor cells. PLoS One 2009 2
67 19673543 Analysis of Ewing sarcoma (EWS)-binding proteins: interaction with hnRNP M, U, and RNA-helicases p68/72 within protein-RNA complexes. J Proteome Res 2009 Oct 3
68 19820381 Primary vulvar Ewing sarcoma/primitive neuroectodermal tumor: a report of 2 cases and review of the literature. Int J Gynecol Cancer 2009 Aug 1
69 20051954 EWS-Oct-4B, an alternative EWS-Oct-4 fusion gene, is a potent oncogene linked to human epithelial tumours. Br J Cancer 2010 Jan 19 2
70 20211855 Identification of a self-association domain in the Ewing's sarcoma protein: a novel function for arginine-glycine-glycine rich motifs? J Biochem 2010 Jun 1
71 20362353 The arylstibonic acid compound NSC13746 disrupts B-ZIP binding to DNA in living cells. Eur J Cell Biol 2010 Jul 1
72 20564078 Platelet-derived growth factor receptor beta inhibition increases tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sensitivity: imatinib and TRAIL dual therapy. Cancer 2010 Aug 15 3
73 20730888 Temsirolimus for metastatic desmoplastic small round cell tumor. Pediatr Blood Cancer 2010 Dec 15 1
74 20933505 FOXO1 is a direct target of EWS-Fli1 oncogenic fusion protein in Ewing's sarcoma cells. Biochem Biophys Res Commun 2010 Nov 5 4
75 20972445 Cotranscriptional exon skipping in the genotoxic stress response. Nat Struct Mol Biol 2010 Nov 4
76 21115923 Myxoid liposarcoma with EWS-CHOP type 1 fusion gene. Anticancer Res 2010 Nov 3
77 21185830 Discovery of two novel EWSR1/ATF1 transcripts in four chimerical transcripts-expressing clear cell sarcoma and their quantitative evaluation. Exp Mol Pathol 2011 Apr 1
78 21244633 Identification of Ewing's sarcoma protein as a G-quadruplex DNA- and RNA-binding protein. FEBS J 2011 Apr 5
79 21403840 Ecteinascidin 743 interferes with the activity of EWS-FLI1 in Ewing sarcoma cells. Neoplasia 2011 Feb 5
80 21438137 Mutational analysis reveals the FUS homolog TAF15 as a candidate gene for familial amyotrophic lateral sclerosis. Am J Med Genet B Neuropsychiatr Genet 2011 Apr 1
81 21561087 Loop lengths of G-quadruplex structures affect the G-quadruplex DNA binding selectivity of the RGG motif in Ewing's sarcoma. Biochemistry 2011 Jun 14 6
82 21647358 Tyrosine Phosphorylation in the C-Terminal Nuclear Localization and Retention Signal (C-NLS) of the EWS Protein. Sarcoma 2011 1
83 21771572 Macrophage infiltration predicts a poor prognosis for human ewing sarcoma. Am J Pathol 2011 Sep 1
84 21816343 The Ewing sarcoma protein regulates DNA damage-induced alternative splicing. Mol Cell 2011 Aug 5 3
85 21960059 miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy. J Pathol 2012 Apr 2
86 22019700 A fraction of the transcription factor TAF15 participates in interactions with a subset of the spliceosomal U1 snRNP complex. Biochim Biophys Acta 2011 Dec 1
87 22323082 Small-molecule screen identifies modulators of EWS/FLI1 target gene expression and cell survival in Ewing's sarcoma. Int J Cancer 2012 Nov 1 1
88 22363068 Phase II study of sequential gemcitabine followed by docetaxel for recurrent Ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: results of Sarcoma Alliance for Research Through Collaboration Study 003. Oncologist 2012 4
89 22569967 NR4A3 rearrangement reliably distinguishes between the clinicopathologically overlapping entities myoepithelial carcinoma of soft tissue and cellular extraskeletal myxoid chondrosarcoma. Virchows Arch 2012 Jun 1
90 22587874 Molecular pathogenesis and targeted therapeutics in Ewing sarcoma/primitive neuroectodermal tumours. Clin Sarcoma Res 2012 Feb 1 1
91 22771914 Domains involved in TAF15 subcellular localisation: dependence on cell type and ongoing transcription. Gene 2012 Sep 15 2
92 22851904 Topotecan and cyclophosphamide in adults with relapsed sarcoma. Sarcoma 2012 3
93 23024594 DNA methylation and gene expression profiling of ewing sarcoma primary tumors reveal genes that are potential targets of epigenetic inactivation. Sarcoma 2012 4
94 23252871 Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion, resembling extraskeletal myxoid chondrosarcoma: Case report with a review of Literature. Pathol Int 2012 Dec 2
95 23284935 Influence of the internalization pathway on the efficacy of siRNA delivery by cationic fluorescent nanodiamonds in the Ewing sarcoma cell model. PLoS One 2012 1
96 23497288 miR-125b develops chemoresistance in Ewing sarcoma/primitive neuroectodermal tumor. Cancer Cell Int 2013 Mar 4 16
97 23741244 Clinicopathological investigation of four cases of desmoplastic small round cell tumor. Oncol Lett 2012 Sep 1
98 23857410 The dual inhibitory effect of thiostrepton on FoxM1 and EWS/FLI1 provides a novel therapeutic option for Ewing's sarcoma. Int J Oncol 2013 Sep 5
99 23894528 Differential disruption of EWS-FLI1 binding by DNA-binding agents. PLoS One 2013 4
100 23951165 EphA2-induced angiogenesis in ewing sarcoma cells works through bFGF production and is dependent on caveolin-1. PLoS One 2013 1